Ignite Creation Date:
2024-05-05 @ 11:18 PM
Last Modification Date:
2024-10-26 @ 10:32 AM
Study NCT ID:
NCT01301898
Status:
COMPLETED
Last Update Posted:
2012-02-14
First Post:
2011-02-22
Brief Title:
To Evaluate the Safety and Efficacy of GC1111 Recombinant Human Iduronate-2-sulfatase in Hunter Syndrome Patients
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-05
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-22
First Submit QC Date:
February 22 2011
Study First Post Date:
2011-02-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-02-12
Last Update Post Date:
2012-02-14
Last Update Post Date Type:
ESTIMATED